1. Home
  2. JACK vs NGEN Comparison

JACK vs NGEN Comparison

Compare JACK & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jack In The Box Inc.

JACK

Jack In The Box Inc.

HOLD

Current Price

$11.61

Market Cap

260.2M

ML Signal

HOLD

NGEN

NervGen Pharma Corp. Common stock

N/A

Current Price

$3.98

Market Cap

317.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
JACK
NGEN
Founded
1951
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
260.2M
317.6M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
JACK
NGEN
Price
$11.61
$3.98
Analyst Decision
Hold
Analyst Count
15
0
Target Price
$23.47
N/A
AVG Volume (30 Days)
766.7K
99.9K
Earning Date
02-18-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,465,314,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.58
$3.55
52 Week High
$31.25
$5.93

Technical Indicators

Market Signals
Indicator
JACK
NGEN
Relative Strength Index (RSI) 19.57 45.25
Support Level N/A $3.69
Resistance Level $20.96 $4.44
Average True Range (ATR) 0.64 0.28
MACD -0.20 0.02
Stochastic Oscillator 1.20 52.86

Price Performance

Historical Comparison
JACK
NGEN

About JACK Jack In The Box Inc.

Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: